BioCorRx (BICX) Amortization of Deferred Charges (2015 - 2025)

BioCorRx (BICX) posted Amortization of Deferred Charges of $1877.0 for Q4 2025, down 96.33% sequentially from $51198.0 in Q1 2025, and down 98.15% YoY from $101725.0 in Q4 2024.

BioCorRx (BICX) Amortization of Deferred Charges (2015 - 2025) Analysis & Trends

BioCorRx (BICX) has 5 years of Amortization of Deferred Charges data on file, last reported at $1877.0 in Q4 2025.

  • Quarterly Amortization of Deferred Charges fell 98.15% year-over-year to $1877.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $154800.0 (up 1.23% YoY) and the FY2025 annual result came in at $55738.0, down 91.03% from the prior year.
  • Amortization of Deferred Charges slipped to $1877.0 in Q4 2025 per BICX's latest filing, from $51198.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $101725.0 in Q4 2024, with the low at $1877.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 BioCorRx 10,406.16 -374,763.84 189,355.00

Historic Data

Download Data
DateValue
Dec 31, 2025 1,877.00
Dec 31, 2025 1,877.00
Mar 31, 2025 51,198.00
Mar 31, 2025 51,198.00
Dec 31, 2024 101,725.00
Dec 31, 2024 101,725.00
Mar 31, 2017 9.36 Mn
Mar 31, 2017 9.36 Mn
Dec 31, 2016 45,152.00
Dec 31, 2016 45,152.00
Mar 31, 2016 21,722.00
Mar 31, 2016 21,722.00
Dec 31, 2015 35,488.00
Dec 31, 2015 35,488.00
Sep 30, 2015 48,234.00
Sep 30, 2015 48,234.00
Jun 30, 2015 14,966.00
Jun 30, 2015 14,966.00
Mar 31, 2015 71,354.00
Mar 31, 2015 71,354.00